# Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers

> **NCT04630379** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 16 (actual)

## Conditions studied

- Glioblastoma
- Malignant Glioma
- WHO Grade III Glioma

## Interventions

- **OTHER:** Palliative Therapy
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Supportive Care
- **OTHER:** Survey Administration

## Key facts

- **NCT ID:** NCT04630379
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-13
- **Primary completion:** 2019-06-13
- **Final completion:** 2020-08-31
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04630379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04630379, "Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04630379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
